Published in Arch Environ Health on December 01, 2004
Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs. PLoS One (2009) 0.90
The Upper Midwest Health Study: a case-control study of pesticide applicators and risk of glioma. Environ Health (2012) 0.77
The Upper Midwest Health Study: industry and occupation of glioma cases and controls. Am J Ind Med (2012) 0.76
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev (2010) 12.60
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol (2003) 12.24
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst (2012) 11.91
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA (2011) 6.45
Long-term mortality after screening for colorectal cancer. N Engl J Med (2013) 5.81
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol (2008) 4.49
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology (2005) 4.31
Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer (2013) 4.24
Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int (2008) 3.51
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J Clin Oncol (2005) 3.50
The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer (2007) 3.44
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma. J Clin Oncol (2005) 3.41
Utilization of surveillance colonoscopy in community practice. Gastroenterology (2009) 3.33
Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.08
Exposure to hazardous workplace noise and use of hearing protection devices among US workers--NHANES, 1999-2004. Am J Ind Med (2009) 2.69
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol (2008) 2.58
Texaco and its consultants. Int J Occup Environ Health (2005) 2.55
Hearing difficulty attributable to employment by industry and occupation: an analysis of the National Health Interview Survey--United States, 1997 to 2003. J Occup Environ Med (2008) 2.45
Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer (2007) 2.43
Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am J Clin Nutr (2002) 2.40
Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med (2012) 2.35
NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. Int J Cancer (2006) 2.16
Prevalence of dermatitis in the working population, United States, 2010 National Health Interview Survey. Am J Ind Med (2012) 2.16
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med (2009) 1.94
Acute illnesses associated with pesticide exposure at schools. JAMA (2005) 1.88
Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev (2008) 1.86
Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. J Urol (2010) 1.83
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group. Cancer (2008) 1.80
Multiple myeloma: a review of the epidemiologic literature. Int J Cancer (2007) 1.78
Exposure misclassification in studies of agricultural pesticides: insights from biomonitoring. Epidemiology (2006) 1.77
Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst (2007) 1.73
Research recommendations for selected IARC-classified agents. Environ Health Perspect (2010) 1.73
Asthma and farm exposures in a cohort of rural Iowa children. Environ Health Perspect (2005) 1.71
Hypothesis: oxidative stress score as a combined measure of pro-oxidant and antioxidant exposures. Ann Epidemiol (2007) 1.69
Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst (2004) 1.67
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. J Clin Oncol (2008) 1.65
Cohort mortality study of workers at seven beryllium processing plants: update and associations with cumulative and maximum exposure. Occup Environ Med (2010) 1.62
Glyphosate biomonitoring for farmers and their families: results from the Farm Family Exposure Study. Environ Health Perspect (2004) 1.62
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741. J Clin Oncol (2010) 1.61
The prevalence of weight concerns in a smoking abstinence clinical trial. Addict Behav (2005) 1.60
Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol (2010) 1.58
Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey. BMC Cardiovasc Disord (2008) 1.55
A bibliometric analysis of scientific production in cancer molecular epidemiology. Carcinogenesis (2007) 1.54
Pesticide contamination inside farm and nonfarm homes. J Occup Environ Hyg (2005) 1.52
Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005. J Clin Oncol (2009) 1.49
Polychlorinated biphenyls and neurodegenerative disease mortality in an occupational cohort. Epidemiology (2006) 1.46
Decrease in 4-aminobiphenyl-induced methemoglobinemia in Cyp1a2(-/-) knockout mice. Toxicol Appl Pharmacol (2002) 1.44
Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites. J Natl Med Assoc (2008) 1.42
Assessment of occupational cosmic radiation exposure of flight attendants using questionnaire data. Aviat Space Environ Med (2011) 1.42
How many deaths will it take? A death from asthma associated with work-related environmental tobacco smoke. Am J Ind Med (2008) 1.42
Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336. J Clin Oncol (2008) 1.41
Tenth revision U.S. mortality rates for use with the NIOSH Life Table Analysis System. J Occup Environ Med (2006) 1.41
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol (2004) 1.40
Urinary pesticide concentrations among children, mothers and fathers living in farm and non-farm households in iowa. Ann Occup Hyg (2006) 1.39
The prevalence of short sleep duration by industry and occupation in the National Health Interview Survey. Sleep (2010) 1.39
Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev (2012) 1.36
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. J Clin Oncol (2003) 1.36
Potential occupational risks for neurodegenerative diseases. Am J Ind Med (2005) 1.35
Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study. J Neurol (2003) 1.35
Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995–2004 (United States). Cancer Causes Control (2009) 1.33
Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol Cell Biol (2007) 1.31
The impact of health insurance status on stage at diagnosis of oropharyngeal cancer. Cancer (2007) 1.30
Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum (2002) 1.29
Trends in worker hearing loss by industry sector, 1981-2010. Am J Ind Med (2015) 1.29
Uses of and exposure to trichloroethylene in U.S. industry: a systematic literature review. J Occup Environ Hyg (2007) 1.28
Mortality and exposure response among 14,458 electrical capacitor manufacturing workers exposed to polychlorinated biphenyls (PCBs). Environ Health Perspect (2006) 1.25
ASCO Provisional Clinical Opinion: KRAS, Cetuximab, and Panitumumab-Clinical Implications in Colorectal Cancer. J Oncol Pract (2009) 1.24
Plantation work and risk of Parkinson disease in a population-based longitudinal study. Arch Neurol (2002) 1.23
Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer (2002) 1.23
Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis? Arch Otolaryngol Head Neck Surg (2007) 1.22
Highway repair: a new silicosis threat. Am J Public Health (2004) 1.22
Dioxin and cancer: a critical review. Regul Toxicol Pharmacol (2003) 1.22
Changes in smoking prevalence among U.S. adults by state and region: Estimates from the Tobacco Use Supplement to the Current Population Survey, 1992-2007. BMC Public Health (2011) 1.21
Prevalence of connective tissue disease in silicosis (1985-2006)-a report from the state of Michigan surveillance system for silicosis. Am J Ind Med (2010) 1.20
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial. Mayo Clin Proc (2006) 1.20
Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev (2009) 1.19
Occupational nanosafety considerations for carbon nanotubes and carbon nanofibers. Acc Chem Res (2012) 1.18
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer. Clin Colorectal Cancer (2006) 1.18
Impact of poor retention in HIV medical care on time to viral load suppression. J Int Assoc Provid AIDS Care (2014) 1.17
Maternal exposure to polycyclic aromatic hydrocarbons and 5'-CpG methylation of interferon-γ in cord white blood cells. Environ Health Perspect (2012) 1.17
Work-related asthma among health care workers: surveillance data from California, Massachusetts, Michigan, and New Jersey, 1993-1997. Am J Ind Med (2005) 1.17
Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma. Cancer Res (2011) 1.16